Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Carcinoma, Ductal, Breast × 30 days × Clear all

Phase

Phase NA 3 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 89 Carcinoma, Non-Small-Cell Lung 86 Prostatic Neoplasms 59 Neoplasms 59 Multiple Myeloma 57 Neoplasm Metastasis 53 Colorectal Neoplasms 45 Lung Neoplasms 43 Leukemia, Myeloid, Acute 43 Squamous Cell Carcinoma of Head and Neck 38 Ovarian Neoplasms 35 Carcinoma, Hepatocellular 35 Lymphoma 32 Triple Negative Breast Neoplasms 31 Sarcoma 30 Melanoma 30 Glioma 28 Carcinoma, Renal Cell 27 Pancreatic Neoplasms 26 Brain Neoplasms 25 Stomach Neoplasms 24 Small Cell Lung Carcinoma 24 Hematologic Neoplasms 24 Urinary Bladder Neoplasms 23 Recurrence 23 Rectal Neoplasms 23 Lymphoma, Non-Hodgkin 23 Leukemia, Lymphocytic, Chronic, B-Cell 23 Lymphoma, Large B-Cell, Diffuse 22 Glioblastoma 22

Interventions

acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03947151 2026-03-31

DEGASTIM

Assistance Publique - Hôpitaux de Paris

Phase 2 Completed

Carcinoma, Ductal, Breast

Data powered by HemOnc (CC BY 4.0) Colophon ⚡